BRIEF-GoodRx Holdings Q4 Adjusted Net Income USD 29 Million Vs. IBES Estimate USD 32 Million

Reuters
Feb 26
BRIEF-GoodRx Holdings Q4 Adjusted Net Income USD 29 Million Vs. IBES Estimate USD 32 Million

Feb 25 (Reuters) - GoodRx Holdings Q4 net income USD 5.4 million.

  • Q4 revenue USD 194.8 million vs. IBES estimate USD 193.3 million
  • Q4 adjusted EBITDA USD 65 million vs. IBES estimate USD 64.9 million
  • Q4 adjusted EBITDA margin 33.4%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10